diaDexus Secures $40 Million in Series E Funding

diaDexus Inc., a South San Francisco-based developer of a blood test for the prediction of cardiovascular disease, has raised $40 million in Series E funding. Baker Brothers Advisors LLC and Scale Venture Partners, co-led the deal, and were joined by Burrill & Co. and return backers GlaxoSmithKline, Rho Ventures, Bain Capital’s Brookside Fund and Mosaix Ventures. www.diadexus.com